Literature DB >> 17344352

Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay.

L Joseph Wheat1, Emily Hackett, Michelle Durkin, Patricia Connolly, Ruta Petraitiene, Thomas J Walsh, Kenneth Knox, Chadi Hage.   

Abstract

We observed false-positive results in the Platelia Aspergillus enzyme-linked immunoassay (EIA) for specimens from patients with histoplasmosis and mice with experimental infection. Platelia Aspergillus EIA-positive specimens were negative in the second-generation Histoplasma antigen EIA. Care must be taken to exclude histoplasmosis for patients with positive Platelia Aspergillus EIA results.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17344352      PMCID： PMC1865624          DOI： 10.1128/CVI.00479-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  4 in total

1.  Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Alia A Sarafandi; Amy M Kelaher; Caron A Lyman; Heather E Casler; Tin Sein; Andreas H Groll; John Bacher; Nilo A Avila; Thomas J Walsh
Journal:  J Infect Dis       Date:  2003-06-04       Impact factor: 5.226

2.  Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay.

Authors:  L J Wheat; P Connolly; M Durkin; B K Book; M D Pescovitz
Journal:  Transpl Infect Dis       Date:  2006-12       Impact factor: 2.228

Review 3.  Galactomannan antigen detection in the diagnosis of invasive aspergillosis.

Authors:  Virginia Verdaguer; Thomas J Walsh; William Hope; Karoll J Cortez
Journal:  Expert Rev Mol Diagn       Date:  2007-01       Impact factor: 5.225

4.  Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

Authors:  P Connolly; J Wheat; C Schnizlein-Bick; M Durkin; S Kohler; M Smedema; J Goldberg; E Brizendine; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191
  4 in total
  46 in total

Review 1.  Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.

Authors:  Themistoklis K Kourkoumpetis; Beth Burgwyn Fuchs; Jeffrey J Coleman; Athanasios Desalermos; Eleftherios Mylonakis
Journal:  Clin Infect Dis       Date:  2012-02-23       Impact factor: 9.079

2.  Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay.

Authors:  Anna Maria Tortorano; Maria Carmela Esposto; Anna Prigitano; Anna Grancini; Cristina Ossi; Caterina Cavanna; Giuliana Lo Cascio
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa.

Authors:  Rafael Borrás; Patricia Roselló; Marifina Chilet; Dayana Bravo; Juan García de Lomas; David Navarro
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

4.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.

Authors:  Blanca Samayoa; Monika Roy; Angela Ahlquist Cleveland; Narda Medina; Dalia Lau-Bonilla; Christina M Scheel; Beatriz L Gomez; Tom Chiller; Eduardo Arathoon
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

5.  Platelia Aspergillus assay for diagnosis of disseminated histoplasmosis.

Authors:  S Ranque; R Pelletier; A Michel-Nguyen; F Dromer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

6.  Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.

Authors:  Melissa O Xavier; Alessandro C Pasqualotto; Isabel Cristina E Cardoso; Luiz Carlos Severo
Journal:  Clin Vaccine Immunol       Date:  2008-11-19

7.  Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.

Authors:  Johan Maertens; Griet Huysmans; Koen Theunissen
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

8.  Nonculture diagnostic methods for invasive fungal infections.

Authors:  L Joseph Wheat
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

Review 9.  Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

Authors:  S Moura; L Cerqueira; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-13       Impact factor: 3.267

Review 10.  PCR-based diagnosis of human fungal infections.

Authors:  Prasanna D Khot; David N Fredricks
Journal:  Expert Rev Anti Infect Ther       Date:  2009-12       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.